Enzo Biochem, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 15   

Articles published

ENZ 5.32 -0.32 (-5.67%)
price chart
Enzo Biochem Inc. (ENZ) Drops 5.67% on September 19
Enzo Biochem Inc. ($ENZ) was one of the Russell 2000's biggest losers for September 19 as the stock slid 5.67% to $5.32, a loss of $0.32 per share.
Active Watch List: TriQuint Semiconductor (NASDAQ:TQNT), LiveDeal ...
On July 29, Enzo Biochem Inc. (NYSE:ENZ) announced that U.S. District Judge Leonard P. Stark has established August 18th as the date for a patent claim construction hearing, also called a Markman hearing, involving Enzo Life Science's U.S.
News Buzz : Cree (NASDAQ:CREE), Newmont Mining Corporation (NYSE:NEM ...
Enzo Biochem, Inc. (NYSE:ENZ), a week ago announced the leading authority in Women's health Diagnostics, Thomas C. Wright, MD, joined the company as a consulting pathologist.
Hot News: Cisco Systems, Inc. (NASDAQ:CSCO), Citigroup Inc. (NYSE:C ...
... Inc. and Rocky Holding, Inc. TriQuint Semiconductor, Inc. (NASDAQ:TQNT) has 0.30% insider ownership while its institutional ownership stands at 88.40%.
Indefiniteness After The Supreme Court Nautilus Decision � A Very �Delicate ...
AOL, Inc., Appeal no. 2013-1282, -1283, -1284, -1285 (Fed. Cir. Sept. 10, 2014), the appealed indefiniteness finding by the district court was affirmed by the Fed.
Related articles »  
Global NASH market is expected to reach $1.6 bn by 2020, says Allied Market ...
... and are collaborating with private research and academic institutes to conduct clinical trials. Key companies profiled in the report are: Genfit, Gilead Science, Novo Nordisk, Intercepts Pharmaceuticals, Enzo Biochem, Inc. and Raptor Pharmaceutical ...
Global Uveitis Market 2014-2018.pdf
Uveitis is defined as the inflammation of the middle layer of the eye i.e. the uvea, also known as the uceal tract. The uvea consists of the iris, choroid and ciliary body.
Related articles »